Therefore, increasing the knowledge of DAPK1 interactions of the neuron in ischemic and ischemic-like conditions is a sine qua non condition to broaden the array of molecules susceptible to further functional studies as a strategy in the search for therapies in cerebral ischemia. This evidence concerns the gene DAPK1 and Cerebral ischemia.